Prospects of stem cell therapy for diabetic microvascular complications

The expectations for the clinical application of stem cell therapy for diabetic microvascular complications are increasing, as stem cell transplantation improves histopathological abnormalities mainly through angiogenesis/protection, nerve elongation/protection, and anti‐inflammatory effects.[Image:...

Descripción completa

Detalles Bibliográficos
Autor principal: Naruse, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807142/
https://www.ncbi.nlm.nih.gov/pubmed/36222711
http://dx.doi.org/10.1111/jdi.13916
_version_ 1784862655742214144
author Naruse, Keiko
author_facet Naruse, Keiko
author_sort Naruse, Keiko
collection PubMed
description The expectations for the clinical application of stem cell therapy for diabetic microvascular complications are increasing, as stem cell transplantation improves histopathological abnormalities mainly through angiogenesis/protection, nerve elongation/protection, and anti‐inflammatory effects.[Image: see text]
format Online
Article
Text
id pubmed-9807142
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98071422023-01-04 Prospects of stem cell therapy for diabetic microvascular complications Naruse, Keiko J Diabetes Investig Editorial The expectations for the clinical application of stem cell therapy for diabetic microvascular complications are increasing, as stem cell transplantation improves histopathological abnormalities mainly through angiogenesis/protection, nerve elongation/protection, and anti‐inflammatory effects.[Image: see text] John Wiley and Sons Inc. 2022-10-12 /pmc/articles/PMC9807142/ /pubmed/36222711 http://dx.doi.org/10.1111/jdi.13916 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Naruse, Keiko
Prospects of stem cell therapy for diabetic microvascular complications
title Prospects of stem cell therapy for diabetic microvascular complications
title_full Prospects of stem cell therapy for diabetic microvascular complications
title_fullStr Prospects of stem cell therapy for diabetic microvascular complications
title_full_unstemmed Prospects of stem cell therapy for diabetic microvascular complications
title_short Prospects of stem cell therapy for diabetic microvascular complications
title_sort prospects of stem cell therapy for diabetic microvascular complications
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807142/
https://www.ncbi.nlm.nih.gov/pubmed/36222711
http://dx.doi.org/10.1111/jdi.13916
work_keys_str_mv AT narusekeiko prospectsofstemcelltherapyfordiabeticmicrovascularcomplications

Ejemplares similares